Mirae Asset Global Investments’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
WA
HWAM
SAM
PMAM
YIH
SFWA
IWA
PFSRSONJ
CUAMC
Mirae Asset Global Investments's PHAT Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Phathom Pharmaceuticals (PHAT) stake by 13% in Q2 2026, selling an estimated $6.2K and leaving 3,567 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.
Mirae Asset Global Investments first reported a position in PHAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.7M in Q2 2022. 16 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.
- Mirae Asset Global Investments held 3,567 shares of Phathom Pharmaceuticals worth $38.7K as of Q2 2026.
- Mirae Asset Global Investments sold 543 Phathom Pharmaceuticals shares in Q2 2026, an estimated $6.2K.
- Phathom Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1397 holding.
- Mirae Asset Global Investments first reported a position in Phathom Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
- Mirae Asset Global Investments's Phathom Pharmaceuticals position peaked at $6.7M in Q2 2022.
- 16 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.